Crescent Grove Advisors’s Foley Trasimene Acquisition Corp. II Units, each consisting of one share of Class A common stock, an BFT.U Stock Holding History

Crescent Grove Advisors’s Portfolio BFT.U Stock Details BFT.U Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-100,000	Closed	-$1.7M	–	217
2020 Q4	$1.7M	Hold	100,000	–	–	0.22%	51
2020 Q3	$1.02M	Buy	+100,000	New	+$1.02M	0.2%	67

Crescent Grove Advisors's BFT.U Position: Q1 2021 in Review

Crescent Grove Advisors sold out of Foley Trasimene Acquisition Corp. II Units, each consisting of one share of Class A common stock, an (BFT.U) in Q1 2021, closing a stake of 100,000 shares — an estimated $1.7M sold.

Crescent Grove Advisors first reported a position in BFT.U in Q3 2020 and held it in 2 quarters. The position peaked at $1.7M in Q4 2020. 0 funds tracked by Wall St. Rank hold BFT.U as of Q1 2021.

Crescent Grove Advisors reported no remaining Foley Trasimene Acquisition Corp. II Units, each consisting of one share of Class A common stock, an position as of Q1 2021 after selling out during the quarter.
Crescent Grove Advisors sold 100,000 Foley Trasimene Acquisition Corp. II Units, each consisting of one share of Class A common stock, an shares in Q1 2021, an estimated $1.7M.
Crescent Grove Advisors first reported a position in Foley Trasimene Acquisition Corp. II Units, each consisting of one share of Class A common stock, an in Q3 2020 and held it in 2 quarters.
Crescent Grove Advisors's Foley Trasimene Acquisition Corp. II Units, each consisting of one share of Class A common stock, an position peaked at $1.7M in Q4 2020.
0 funds tracked by Wall St. Rank held Foley Trasimene Acquisition Corp. II Units, each consisting of one share of Class A common stock, an as of Q1 2021.

Based on Crescent Grove Advisors's 13F filing for Q1 2021, filed 7 May 2021.